Jim Simons Seelos Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.65 - $278.68 $620,284 - $266 Million	-954,284 Reduced 82.66%	200,135 $206,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $286,791 - $522,972	-562,336 Reduced 32.76%	1,154,419 $785,000
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $1.44 Million - $2.94 Million	1,716,755 New	1,716,755 $1.44 Million
Q4 2021 Feb 11, 2022	SELL	$1.59 - $2.38 $251,662 - $376,701	-158,278 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.69 - $2.89 $482,025 - $824,291	-285,222 Reduced 64.31%	158,278 $381,000
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $1.17 Million - $2.8 Million	443,500 New	443,500 $1.17 Million
Q1 2021 May 13, 2021	SELL	$1.35 - $4.99 $948,356 - $3.51 Million	-702,486 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.74 - $2.01 $82,436 - $223,913	111,400 Added 18.85%	702,486 $1.11 Million
Q3 2020 Nov 13, 2020	SELL	$0.6 - $1.25 $233,100 - $485,625	-388,500 Reduced 39.66%	591,086 $554,000
Q2 2020 Aug 13, 2020	SELL	$0.42 - $1.51 $41,493 - $149,177	-98,793 Reduced 9.16%	979,586 $989,000
Q1 2020 May 14, 2020	SELL	$0.47 - $1.56 $18,914 - $62,780	-40,244 Reduced 3.6%	1,078,379 $529,000
Q4 2019 Feb 13, 2020	BUY	$0.72 - $1.52 $78,238 - $165,170	108,665 Added 10.76%	1,118,623 $1.5 Million
Q3 2019 Nov 13, 2019	BUY	$0.92 - $2.15 $74,053 - $173,059	80,493 Added 8.66%	1,009,958 $927,000
Q2 2019 Aug 12, 2019	BUY	$2.11 - $3.3 $955,197 - $1.49 Million	452,700 Added 94.95%	929,465 $2.04 Million
Q1 2019 May 14, 2019	BUY	$1.45 - $8.1 $691,309 - $3.86 Million	476,765 New	476,765 $1.6 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $41.6M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.